1-(2,3-DIFLUORO-4-HYDROXYPHENYL)ETHANONE, 95%, 250mg

2-(4-Chloro-phenyl)-2,6-dihydro-4H-thieno[3,4-c]pyrazol-3-ylamine, 95.0%, 500mg

4-(2,6-Dichloro-4-pyrimidyl)morpholine>98.0%(GC)5g

(1-(3-Methoxyphenyl)cyclobutyl)methanamine, 95+%, 1g

2-Oxo-2,3-dihydro-1,3-benzoxazole-7-carboxylic acid, 98%, 500mg

2-Benzofurancarboxamide, 5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-, hydrochloride (1:1), 98%, 1g

E-plan EPLi S100x/1.25 oil immersion infinity corrected IOS objective. Working distance 0.36 mm

N-Succinimidyl 4-[4-(Dimethylamino)phenylazo]benzoate>98.0%(HPLC)(T)1g

(2S,3R)-3-Hydroxypyrrolidine-2-carboxylic acid, 95.0%, 100mg

2-Bromo-5-phenyl-1,3,4-oxadiazole, 95.0%, 250mg

3-chloro-6-(2-methylphenyl)pyridazine, 95.0%, 500mg

1-(4-Fluorobenzenesulfonyl)azetidine-3-carboxylic acid, 97%, 1g

(5,6-Dimethoxypyridin-2-yl)methanol, 97%, 1g